Uses

Antiplatelet agent used to reduce the risk of cardiovascular death, myocardial infarction, stroke, and stent thrombosis in appropriate patients.

Do not use if

Contraindicated in active bleeding, history of intracranial hemorrhage, or hypersensitivity to ticagrelor.

Bleeding and dyspnea are the most common adverse effects. Bruising and other bleeding manifestations may occur.

May cause serious or fatal bleeding. Assess bleeding risk carefully before procedures or concomitant therapies.

A reversible P2Y12 receptor antagonist that inhibits platelet activation and aggregation.

Store at room temperature protected from moisture.